Sterling Global Strategies’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$354K Hold
22,000
1.97% 12
2018
Q4
$322K Hold
22,000
1.63% 12
2018
Q3
$400K Hold
22,000
1.74% 13
2018
Q2
$371K Hold
22,000
2.39% 12
2018
Q1
$431K Hold
22,000
2.02% 10
2017
Q4
$446K Hold
22,000
1.88% 10
2017
Q3
$382K Hold
22,000
1.56% 16
2017
Q2
$282K Hold
22,000
1.35% 17
2017
Q1
$285K Hold
22,000
1.38% 17
2016
Q4
$217K Hold
22,000
0.88% 21
2016
Q3
$266K Hold
22,000
0.99% 21
2016
Q2
$190K Hold
22,000
0.72% 23
2016
Q1
$208K Hold
22,000
1.06% 22
2015
Q4
$381K Hold
22,000
6.04% 6
2015
Q3
$295K Buy
22,000
+10,000
+83% +$201K 1.63% 10
2015
Q2
$271K Hold
12,000
0.91% 14
2015
Q1
$171K Hold
12,000
0.52% 22
2014
Q4
$116K Buy
+12,000
New +$107K 0.06% 22

Other funds holding HALO

Sterling Global Strategies's HALO Position: Q1 2019 in Review

Sterling Global Strategies held its Halozyme (HALO) position steady in Q1 2019 at 22,000 shares worth $354K. The position accounts for 1.97% of the portfolio, ranked #12.

Sterling Global Strategies first reported a position in HALO in Q4 2014 and has held it in 18 quarters since. The position peaked at $446K in Q4 2017. 201 funds tracked by Wall St. Rank hold HALO as of Q1 2019.

  • Sterling Global Strategies held 22,000 shares of Halozyme worth $354K as of Q1 2019.
  • Sterling Global Strategies left its Halozyme share count unchanged in Q1 2019.
  • Halozyme made up 1.97% of Sterling Global Strategies's portfolio in Q1 2019, its #12 holding.
  • Sterling Global Strategies first reported a position in Halozyme in Q4 2014 and has held it in 18 quarters since.
  • Sterling Global Strategies's Halozyme position peaked at $446K in Q4 2017.
  • 201 funds tracked by Wall St. Rank held Halozyme as of Q1 2019.

Based on Sterling Global Strategies's 13F filing for Q1 2019, filed 15 May 2019.